$363.9 M

ABEO Mkt cap, 04-Dec-2018

$1.7 M

Abeona Therapeutics Revenue Q3, 2018
Abeona Therapeutics Net income (Q3, 2018)-16.4 M
Abeona Therapeutics EBIT (Q3, 2018)-16.9 M
Abeona Therapeutics Cash, 30-Sep-201833.6 M

Abeona Therapeutics Income Statement

Abeona Therapeutics Balance Sheet

Annual

USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017

Cash

424.0k11.5m40.1m69.1m137.8m

Accounts Receivable

74.0k115.0k107.0k

Inventories

77.0k315.0k155.0k

Current Assets

575.0k11.6m40.6m69.4m140.6m

PP&E

6.0k4.0k350.0k721.0k1.4m

Goodwill

32.5m32.5m32.5m

Total Assets

613.0k16.6m80.1m111.1m178.8m

Accounts Payable

863.0k1.9m875.0k3.7m2.4m

Dividends Payable

6.7m

Current Liabilities

9.0m2.9m1.5m8.3m5.6m

Total Liabilities

15.4m12.3m12.0m8.7m

Additional Paid-in Capital

251.4m300.7m378.0m431.2m529.4m

Retained Earnings

(266.4m)(296.1m)(310.6m)(332.5m)(359.8m)

Total Equity

(14.8m)4.8m67.7m99.1m170.1m

Financial Leverage

0 x3.4 x1.2 x1.1 x1.1 x

Abeona Therapeutics Cash Flow

Annual

USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017

Net Income

4.4m(26.8m)(14.5m)(21.9m)(27.3m)

Depreciation and Amortization

3.0k11.0k551.0k825.0k741.0k

Accounts Receivable

766.0k(79.0k)(9.0k)17.0k

Inventories

194.0k77.0k(287.0k)160.0k

Accounts Payable

(1.2m)33.0k(1.2m)2.8m(1.3m)

Cash From Operating Activities

1.0k(1.6m)(10.4m)(13.0m)(22.9m)

Cash From Investing Activities

(2.0k)3.4m(519.0k)

Cash From Financing Activities

29.0k12.7m35.7m42.5m92.4m

Interest Paid

7.0k7.0k6.0k8.0k

Free Cash Flow

(1.0k)(1.6m)(10.7m)(13.5m)(23.8m)

Abeona Therapeutics Ratios

USDY, 2018

Financial Leverage

1.1 x
Report incorrect company information